Carbamic Acid

Carbamic Acid

SCHEMBL4466151

NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 1.00
LMNA P02545 5/20 0.62
ALDH1A1 P00352 4/20 0.62
TDP1 Q9NUW8 4/20 0.62
OR51E2 Q9H255 2/20 0.62
LDHA P00338 3/20 0.60
LDHB P07195 1/20 0.60
BLM P54132 5/20 0.50
PMP22 Q01453 4/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
ALOX15 P16050 2/20 0.50
CA1 P00915 1/20 0.50
CYP3A4 P08684 4/20 0.42
TSHR P16473 4/20 0.42
HSD17B10 Q99714 3/20 0.42
NFKB1 P19838 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 2/20 0.42
THPO P40225 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL2 1.00
Carbamic Acid SCHEMBL4456232 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL30787477 1.00
Carbamic Acid SCHEMBL5048206 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL8512703 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL75781 1.00
Carbamic Acid SCHEMBL570938 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL630836 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL2564971 1.00 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL27692345 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149608-A1 Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins MISSISSIPPI STATE UNIVERSITY 2009-06-11 US claimed
CN-117940484-A Star pAsp-oligoamine derivatives 多肽治疗解决公司 2024-04-26 CN disclosed
WO-2009091350-A1 POLYCARBAMIDES, POLYCARBAMATES, AND POLYCARBAMIDE-FORMALDEHYDE AND POLYCARBAMATE-FORMALDEHYDE CONDENSATION RESINS MISSISSIPPI STATE UNIVERSITY (US) 2009-07-23 WO disclosed
US-20090149608-A1 Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins MISSISSIPPI STATE UNIVERSITY 2009-06-11 US disclosed
EP-1370622-B1 CARBAMATE-FUNCTIONAL, RESINS AND THEIR USE IN HIGH SOLIDS COATING COMPOSITIONS BASF CORP (US) 2005-07-06 EP disclosed
EP-1370622-A2 CARBAMATE-FUNCTIONAL, RESINS AND THEIR USE IN HIGH SOLIDS COATING COMPOSITIONS Basf Corporation (US) 2003-12-17 EP disclosed
US-6462144-B1 CARBAMATE FUNCTIONALIZED STAR OR HYPERBRANCHED POLYOLS AS REACTIVE RESINS IN COATINGS WITH GOOD WEAR RESISTANCE BASF CORPORATION 2002-10-08 US disclosed
US-20020136901-A1 Carbamate-functional resins and their use in high solids coating compositions BASF CORPORATION 2002-09-26 US disclosed
WO-2002068553-A2 CARBAMATE-FUNCTIONAL, RESINS AND THEIR USE IN HIGH SOLIDS COATING COMPOSITIONS BASF CORPORATION (US) 2002-09-06 WO disclosed
US-20020119320-A1 Carbamate-functional resins and their use in high solids coating compositions BASF CORPORATION 2002-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149608-A1 Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins SUV39H1, PFAS, SUV39H2 ACHE 2967/4885LMNA 953/4885ALDH1A1 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.